期刊文献+

雌激素在大鼠腹主动脉瘤形成中的作用 被引量:4

The role of estrogen in the formation and development of abdominal aortic aneurysm:experiment with rats
原文传递
导出
摘要 目的研究雌激素在大鼠腹主动脉瘤(AAA)形成中的作用,探讨雌激素对腹主动脉瘤抑制作用的机制。方法雄性 Wistar 大鼠20只,随机分为实验组、对照组各10只。实验组定期腹腔内注射雌二醇,对照组定期腹腔内注射生理盐水(NS),分别用弹性蛋白酶灌注肾下腹主动脉制成AAA 模型。14 d 后用放射免疫法检测血清雌二醇的含量,用免疫组织化学、实时荧光定量聚合酶链反应(Real-Time PCR)测定动脉瘤组织基质金属蛋白酶2、9(MMP-2、9)的 mRNA 及蛋白的表达。结果实验组与对照组比较雌二醇水平显著增高,P<0.01。其动脉瘤扩张率分别为(103±4)%和(172±13)%(P<0.01)、MMP-2 mRNA 的相对表达量分别为0.07±0.04和0.22±0.07(P<0.01)、MMP-9 mRNA 的相对表达量分别为1.4±0.7和7.4±2.8(P<0.01)、MMP-2的表达率分别为(22±3)%和(50±12)%(P<0.01)、MMP-9的表达率分别为(23±2)%和(45±10)%(P<0.01)。结论在腹主动脉瘤形成的过程中雌激素可能通过降低 MMP-2、9的 mRNA 表达、蛋白合成及减少炎性细胞浸润来抑制腹主动脉瘤的形成。 Objective To investigate the role of estrogen in the formation and development of abdominal aortic aneurysm (AAA). Methods Twenty male Wister rats were randomly divided into 2 equal groups: experiment group, injected with 17-βestradiol (E2 ) intraperitoneally 1 week before the establishment of AAA once a day for 3 weeks ( until 2 weeks after the establishment of AAA), and underwent infusion of pancreatic elastase into the infrarenal abdominal aorta through a catheter inserted into the left common iliac artery o as to establish the AAA model, and control group, injected with normal saline intraperitoneally for 3 weeks. Two weeks after the establishment of AAA model, the rats underwent laparotomy, blood samples were collected from vena cava inferior to detect the level of E2 by radioimmunoassay and then the aneurysms were harvested to undergo immunohistochemistry and real-time PCR to detect the protein expression and mRNA expression of matrix metalloproteinase (MMP) -2 and MMP- 9. Results The plasma E2 level of the experiment group was (28 ±6) pg/ml, significantly higher than that of the control group [ (5.86 ± 0.24) pg/ml, P 〈 0.01 ]. The aorta dilatation rate of the experiment group was (103 ±4)%, significantly lower than that of the control group [ (172 ±13)%, P 〈0.01]. The destruction of arterial wail, degradation of elastic fibers, and infiltration of inflammatory cells were all more severe in the control group than in the experiment group. The relative mRNA expression of MMP-2 of the experiment group was 0.07 ± 0.04, significantly lower than that of the control group (0.22 ± 0.07, P 〈 0. 01 ) ; and the relative mRNA expression of MMP-9 of the experiment group was 1.4 ± 0.7, significantly lower than that of the control group ( 7.4 ± 2. 8, P 〈 0.01 ). The protein expression of MMP-2 of the experiment group was (22 ±3)%, significantly lower than that of the control group [ (50 ± 12)%, P 〈 0. 01 ], and the protein expression of MMP-9 of the experiment group was (23 ± 2) %, significantly lower than that of the control group too [ (45 ± 10) %, P 〈 0. 01 ]. Conclusions Estrogen inhibits the AAA formation and development by reducing the MMP-2 and MMP-9 mRNA and protein expression and the infiltration of inflammatory cells.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第7期471-474,共4页 National Medical Journal of China
基金 国家自然科学基金(30471706)
关键词 动脉瘤 雌激素类 基质金属蛋白酶 大鼠 Aneurysm Estrogens Matrix metalloproteinases Rats
  • 相关文献

参考文献16

  • 1Wills A,Thompson MM,Crowther M,et al.Pathogensis of abdominal aortic aneurysm-cellular and biochemical mechanisms.Eur J Vasc Endovasc Surg,1996,12:391-400.
  • 2Pleumeekers HJ,Hoes AW,Vzn der DE,et al.Aneurysms of the abdominal aorta in older adults.The Rotterdam study.Am J Epidemiol,1995,142:1291-1299.
  • 3Singh K,Bonaa KH,Jacobsen BK,et al.Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study.Am J Epidemiol,2001,154:236-244.
  • 4段志泉,张平.腹主动脉瘤.段志泉,张强,主编.实用血管外科学.第1版.辽宁:辽宁科技出版社,1999.262-304.
  • 5刘应才,季汉华.雌激素抑制动脉粥样硬化的细胞机制[J].国外医学(妇产科学分册),1999,26(5):266-269. 被引量:6
  • 6闫训友,薛冲,刘志敏,张惟广.基质金属蛋白酶及其组织抑制剂研究进展[J].生物技术通讯,2004,15(3):302-305. 被引量:36
  • 7Martin-McNulty B,Tham DM,Da CV,et al.17β-estradiol attenuates development of angiotensin Ⅱ -induced aortic abdominal aneurysm in apolipoprotein E-deficient mice.Arterioscler Thromb Vasc Bio1,2003,23:1627-1632.
  • 8杨学辉,李恩,佟晓旭.雌激素对去卵巢大鼠骨Ⅰ型胶原表达及基质金属蛋白酶活性的影响[J].生物化学与生物物理进展,2001,28(4):519-522. 被引量:13
  • 9Freestone T.Inflammation and matrix metalloproteinasea in the enlarging abdominal aortic aneurysm.Arterioscler Thromb Vasc Biol,1995,15:1145-1151.
  • 10Tamarina NA,McMillan WD,Shively VP,et al.Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta.Surgery,1997,122:264-271.

二级参考文献30

  • 1张修武,郭实士.湖南藉汉族人HLA-DP座位的寡核苷酸分型[J].免疫学杂志,1993,9(1):31-34. 被引量:5
  • 2王新文 张强 等.自体移植静脉内膜增生的动脉内膜变化[J].中华实验外科杂志,1998,15:539-540.
  • 3Mengshol JA, Vincenti MP, Brinckerhoff CR. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells:requirement for Runx-2 and activation by p38 MAPK and JNK pathways[J]. Nucleic Acids Res, 2001,29(21):4361
  • 4Fang J, Shing Y, Wiederschain D, et al. Matrix metalloproteinase-2 s required for the switch to the angiogenie phenotype in a tumormodel[J]. Proc Natl Acad Sci USA, 2000,97(8):3884
  • 5Itoh Y, Nagase H. Matrix metalloproteinases in cancer[J]. Essays Biochem, 2002;38:21
  • 6Visse R, Hideaki N. Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure, function, and biochemistry[J]. Circ Res, 2003,92:827
  • 7Hojo Y, Ikeda U, Takahashi M, et al. Matrix metalloproteinase-1 expression by interaction between monocytes and vascular endothelial cells[J]. J Mol Cell Cardiol, 2000,32(8):1459
  • 8Kleiner D, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis[J]. Cancer Chemother Phamacol, 1999,43(suppl):42
  • 9Preston A. Matrix metalloproteinases[J]. Cal Biochem, 2002,2:5
  • 10Pang IH, Hellberg PE, Fleenor DI, et al. Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells[J]. Invest Ophthalmol Vis Sci, 2003,44(8):3485

共引文献77

同被引文献53

  • 1Marge B, Lovell RN, Kenneth A, et al. A screening program to identify risk factors for abdominal aortic aneurysms. Can J Surg, 2006,49 : 113-116.
  • 2David C,Jack L,John W, et al. Guidelines for the treatment of abdominal aortic aneurysms: report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg, 2003,37 : 1106 - 1117.
  • 3Norman R, Edward J. A personal experience with factors influencing survivla after elective open repair of infrarenal aortic aneurysms. J Vasc Surg,2005 ,42 :898.
  • 4Crow P, Shaw JJ, Eamshaw KR, et al. A single normal ultrasonographie scan at age 65 years rules out significant aneurysm disease for life in men. Br J Surg ,2001,88:941-944.
  • 5Chew HF, You CK, Brown MG, et al. Mortality, morbidity and costs of ruptured and electice abdominal aortic aneurysm repairs in Nova Scotia. Ann Vasc Surg,2003,17 : 171-179.
  • 6Cornuz J, Sidoti Pinto C, Tevaearai H, et al. Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies. Eur J Public Health, 2004,4 : 343-349.
  • 7Lederle FA, Johnson GR, Wilson SE, et al. Prevalence and associations of abdominal aortic aneurysm detected through screening.Ann Intern Med. 1997.126:441-449.
  • 8Lindblad B, Borner G, Gottsater A. Factors associated with development of large abdominal aortic aneurysm in middle-aged men. Eur J Vasc Endovasc Surg,2005,30:346-352 .
  • 9Crawford ES, Saleh SA, Babb JW, et al. Infrarenal abdominal aortic aneurysm. Factors influencing survival after operation performed over 25-year period. Ann Surg, 1981,193:699-709.
  • 10Charles A, Audra A, Thomas C, et al. Factors affecting outcomes of open surgical repair of pararenal aortic aneyrysms: a 10-year experience. J Vasc Surg,2006,43:921-928.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部